Compounds which can be used to diagnose and monitor diseases associated with the formation of amyloid protein fibrils

Details for Australian Patent Application No. 2002350751 (hide)

International Classifications

Event Publications

20 March 2003 Complete Application Filed

15 July 2004 Application Open to Public Inspection

Published as AU-B-2002350751

18 August 2005 Corrigenda

Applications OPI - Name Index Under the name CETIR CENTRE MEDIC, S.A., Application No. 2002350751, under INID (71) correct the name to read Barnatron, S.A., Catalana De Dispensacion, S.A. and Cetir Centre Medic, S.A.

6 April 2006 Application Accepted

Published as AU-B-2002350751

29 June 2006 Application for Amendment

The nature of the amendment is as shown in the statement(s) Amendments, Section 104 filed 14 Jun 2006. Address for service in Australia - FISHER ADAMS KELLY 13/10 Eagle Street Brisbane QLD 4000 2003

10 August 2006 Standard Patent Sealed

16 November 2006 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 14 Jun 2006 2003

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.